| Literature DB >> 28484316 |
Isra Karaduman1, Derya Karasu1, Canan Yilmaz1, Sedat Oner2, Hilal Erdem Solak1, Gulsen Korfali1.
Abstract
Objective. We aimed to investigate the effect of peritubal local anesthetic and opioid infiltration on pain scores and analgesic consumption in patients who underwent percutaneous nephrolithotomy. Material and Methods. Patients aged between 18 and 65 years and ASA I-III were included in this double-blind, randomized study. The patients were divided into two groups. All patients underwent spinoepidural anesthesia. 20 mL of 0.25 percent bupivacaine + 5 mg morphine (0.5 mL), in Group P (n = 66), infiltrated the renal capsule, perinephric fat, muscles, subcutaneous tissue, and skin under fluoroscopy. In Group C (n = 64), none of the patients received a peritubal injection. In the first 24 h pain scores, time of the first analgesic demand, the mean number of analgesic demands, and postoperative complications were compared between groups. Results. The mean VAS score at postoperative 8, 12, and 24 h and dynamic VAS score at postoperative 4, 8, 12, and 24 h were significantly lower in Group P. VAS score at postoperative 4 h was not significant. Time of the first analgesic demand was significantly longer in Group P. Conclusion. Our study results suggest that peritubal infiltration of bupivacaine with morphine after percutaneous nephrolithotomy is an effective method for postoperative pain control and reduces analgesic consumption.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28484316 PMCID: PMC5412177 DOI: 10.1155/2017/2454267
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1Trial flow diagram.
Patient characteristics [mean ± standard deviation, n, (%)].
| Group P | Group C |
| |
|---|---|---|---|
| Age (year) | 48.53 ± 11 | 48.94 ± 12.3 | 0.84 |
| Sex | 0.88 | ||
| (i) Female | 26, (39.4) | 26, (40.6) | |
| (ii) Male | 40, (60.6) | 48, (59.4) | |
| History of regional anesthesia | 0.41 | ||
| (i) Yes | 18, (27.3) | 13, (20.3) | |
| (ii) No | 48, (72.7) | 51, (79.7) | |
| ASA | 0.50 | ||
| (i) I | 22, (33.3) | 15, (23.4) | |
| (ii) II | 43, (65.2) | 48, (75) | |
| (iii) III | 1, (1.5) | 1, (1.6) | |
| Educational level | 0.40 | ||
| (i) Not being illiterate | 23 (34.8) | 20 (31.3) | |
| (ii) Primary school | 22 (33.3) | 19 (29.7) | |
| (iii) Middle school | 5 (7.6) | 7 (10.9) | |
| (iv) High school | 10 (15.2) | 16 (25) | |
| (v) University | 6 (9.1) | 2 (3.1) |
ASA: American Society of Anesthesiology.
Figure 2Distribution of mean blood pressure according to groups.
Analgesic usage profile of the groups (mean ± standard deviation).
| Group P | Group C |
| |
|---|---|---|---|
| Time of first analgesia (minute) | 262.2 ± 214.4 | 148.8 ± 110.3 |
|
| Number of demand doses | 8.33 ± 8.8 | 16.9 ± 16.4 |
|
| Number of total analgesic doses | 6.05 ± 5 | 10.5 ± 7.7 |
|
p < 0.05.
Figure 3Mean values of Visual Analogue Scale (VAS) according to groups, p < 0.05.
Figure 4Mean values of Dynamic Visual Analogue Scale (DVAS) according to groups, p < 0.05.
The distribution of complications according to groups [n, (%)].
| Modified Clavien Classification | Group P | Group C |
|
|---|---|---|---|
| Grade 1 | |||
| (i) Fever (>38°C) | 1 (1.5) | 2 (3.1) | 0.54 |
| (ii) Nausea | 10 (15.2) | 8 (12.5) | 0.66 |
| (iii) Vomiting | 4 (6.1) | 5 (7.8) | 0.69 |
| (iv) Headache | 7 (10.6) | 4 (6.3) | 0.37 |
| (v) Itching | 2 (3) | 3 (4.7) | 0.62 |
| Grade 2 | |||
| (i) Blood transfusion | 3 (4.5) | 1 (1.6) | 0.32 |
| (ii) Infection | 4 (6.1) | 1 (1.6) | 0.18 |
| Grade 3a | 0 (0) | 0 (0) | |
| Grade 3b | |||
| (i) Arteriovenous fistula | 1 (1.5) | 0 (0) | 0.32 |
| Grade 4 | |||
| (i) Acute Coronary Syndrome | 1 (1.5) | 0 (0) | 0.32 |